TGFB1 and HIV-1 infection: In consideration of the foregoing observations regarding the use of cytokines as immunotherapeutic agents in the treatment and control of HIV-1 infections, we hereby commented on a novel approach of utilizing Transforming Growth Factor- beta (TGF-β) to eradicate latent HIV-provirus pools in HIV patients receiving HAART.